GALT Competitors
Galectin Therapeutics Inc.
$3.71
+$0.07(+1.92%)
42
Overall
40
Value
60
Tech
26
Quality
Market Cap
$367.90M
Volume
119.18K
52W Range
$2.03 - $7.13
Target Price
$11.00
GALT competitors: MEIP, NBIX, NAVB, NBY. Galectin Therapeutics Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
GALT Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| NBIX Neurocrine Biosciences, Inc. | $137.24 | $13.82B | $7.26 | - | 53 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GALT | $3.71 | +1.9% | 119.18K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Galectin Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW